Research looking at the effects of pay-for-performance initiatives often look at large physician practices. A study in the Journal of the American Medical Association instead focuses on small physician practices to determine how quality does or does not improve under pay-for-performance. These small practices are where a majority of Americans still receive care and historically have had worse quality performance. (JAMA Article) The study was conducted among 1-10 physician practices in New York City, largely in poorer neighborhoods, and with offices that implemented EHRs. Some of these small practices received an incentive and some didn’t, on a random assignment basis. The incentive was paid on each patient for whom quality measures improved and was higher for patients whose care likely would be more intensive. The total possible incentive was about 5% of salary. The measures were primarily related to cardiovascular risk–lowering blood pressure and cholesterol, taking daily aspirin and stopping smoking. A total of 84 clinics participated in the study and they had low to moderate performance on the quality measures at baseline, with the exception of lipid levels, which were well controlled. Both the study and control group showed improvement in quality measures during the research period, but the intervention group showed a greater increase in performance on most measures, including use of aspirin and blood pressure control. The authors conclude that the incentive did lead to faster improvement and also attribute it to having an EHR which provided clinical decision support and prompting. Since all groups had the EHR, however, it is not clear that this on its own was a factor. And another shortcoming here is any showing of improvement in end health or economic outcomes.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Cano Health apparently cannot, as it declares bankruptcy due to too much debt. Building primary care centers to serve Medicare, Medicaid and commercial populations, which is Cano’s business, was hot...
February 6, 2024
Turquoise health raises a fresh $30 million in capital for its price transparency platform, as the market for funding health care companies isn’t quite dead yet.
January 24, 2024
I am co-f0under of a company that manages cell and gene therapy for health plans. Cell therapy has made a big difference for many cancer patients but like all new...
January 24, 2024
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace